Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594659 · ClinicalTrials.gov registry record · NA
Development and Efficacy Test of Computerized Treatment for Marijuana Dependence
A NA study of Marijuana Abuse and Dependence, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00594659 is a NA study of Marijuana Abuse and Dependence that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00594659, a NA study of Marijuana Abuse and Dependence, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
More US residents are dependent on marijuana than on any other illicit drug, and the number enrolled in treatment for marijuana continues to increase such that it is now comparable to that for cocaine and heroin. This application seeks to advance the overarching goal to develop and disseminate cost-effective treatments for marijuana dependence that can address this growing problem. The researchers' previous research suggests that an intervention comprising motivational enhancement, cognitive-behavioral, and contingency-management components (MET/CBT/CM) produces greater rates of successful and durable outcomes than has been demonstrated previously. However, three issues relevant to its efficacy and eventual dissemination must be confronted. First, the outcomes achieved can only be characterized as modest; many individuals do not respond to the treatment and relapse rates remain problematic. Second, access is limited by the availability of trained providers. Third, the cost of delivering the treatment is higher than more traditional outpatient interventions. To address these issues, Specific Aim 1 is to develop and test a computer-assisted version of MET/CBT/CM. Computerized treatments have the potential to increase overall effectiveness of treatment services by increasing availability of and access to potent treatments, and by applying innovative technology to enhance outcomes. During Year 1, the intervention will be developed and pilot tested. An interactive program that showed promise in a previous trial for opioid dependence will be modified and enhanced to deliver individualized MET/CBT/CM using effective computer learning technologies. These technologies and access to the MET/CBT/CM program made available via the Internet between treatment sessions and after treatment ends have the potential to promote better learning and more use of coping skills, which in turn can improve outcomes. During Years 2-4 a randomized trial will provide an initial efficacy test of
Conditions Studied
Interventions
- BEHAVIORAL Psychotherapy
- BEHAVIORAL Motivational enhancement therapy
- BEHAVIORAL Computerized Psychotherapy
Study Locations (1)
New Hampshire
- Geisel School of Medicine at Dartmouth - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594659
The ClinicalTrials.gov registry entry for NCT00594659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Marijuana Abuse and Dependence appearing as the primary indexed condition, and to 3 interventions - of which Psychotherapy is the first listed.
NCT00594659 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT00594659 about?
NCT00594659 is a clinical study titled "Development and Efficacy Test of Computerized Treatment for Marijuana Dependence". More US residents are dependent on marijuana than on any other illicit drug, and the number enrolled in treatment for marijuana continues to increase such that it is now comparable to that for cocaine and heroin. This application seeks to advance the overarching goal to develop and disseminate cost-...
What is the current status of trial NCT00594659?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2008-11. Estimated completion is 2012-07.
What conditions does trial NCT00594659 study?
This clinical trial studies the following conditions: Marijuana Abuse and Dependence.
What interventions are being tested in trial NCT00594659?
The interventions under investigation include: Psychotherapy (BEHAVIORAL), Motivational enhancement therapy (BEHAVIORAL), Computerized Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00594659?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00594659 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.